Year
2025202420222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000
Edition number
№6-7 / 2023
REVIEWS
L.A. Kramynin, L.V. Filatova, I.S. Zyuzgin, M.S. Motalkina, S.S. Elkhova, E.V. Dobrovolskaya, A.K. Kovyazin, T.Yu. Semiglazova
Primary mediastinal B-cell lymphoma: evolution and prospects for first-line therapy. Literature review6-15
N.S. Besova
Conversion therapy for stage IV gastric cancer: a review of prognostic factors and patient selection criteria according to the literature data16-27
Ya.A. Yakimenko, V.V. Kutukov, V.V. Antonyan, M.A. Gaziev
Gastrointestinal toxicity during therapy with 5-fluorouracil28-35
M.E. Abramov, T.E. Tikhomirova, O.E. Ryabishina, A.A. Rumyantsev, A.S. Tyulandina
Gastrointestinal stromal tumors: prospects for drug therapy of metastatic or inoperable forms36-41
V.F. Semiglazov, A.V. Komyakhov, S.S. Ereshchenko, T.T. Tabagua, L.P. Gigolaeva, A.I. Tseluyko, A.P. Tergoeva, M.D. Kazantseva, N.S. Amirov, V.V. Mortada, R.S. Pesotsky, D.A. Enaldieva, L.F. Shaikhelislamova, K.S. Nikolaev, E.K. Zhiltsova, P.V. Krivorotko
Treatment of locally advanced (T2-3N0-1M0) and early (T1-2N0M0) HER2-positive breast cancer (clinical experience)42-47
O.O. Gordeeva, N.A. Meshcheryakova, A.A. Meshcheryakov
Lorlatinib in the treatment of ALK-positive non-small cell lung cancer48-53
G.A. Khakimov, G.G. Khakimova, Kh.U. Musurmonov, Sh.G. Khakimova, G.P. Orifzhonova
Pelvic extrusion in patients with cervical cancer: clinical experience54-58
ORIGINAL ARTICLES
R.S. Pesotsky, V.F. Semiglazov, P.V. Krivorotko, T.T. Tabagua, K.Yu. Zernov, A.S. Emelyanov, T.Yu. Semiglazova, N. Amirov, V.V. Mortada, D.G. Ulrikh, V.E. Levchenko, K.Yu. Rychagov, K.Yu. Zirov, V.N. Evseev
Evaluation of long-term results of treatment of patients with residual tumors (including those with minimal forms of ypT1abN0), with pathomorphological complete response (pCR) after neoadjuvant systemic therapy, with primary minimal breast cancer (pT1abN0M0)59-67
S.V. Nedogoda, A.S. Salasyuk, I.N. Barykina, V.O. Lutova, E.A. Popova, M.Yu. Frolov
Clinical and economic study of the use of ibrutinib in combination with venetoclax in patients with chronic lymphocytic leukemia68-80
L.R. Bogatyreva, N.S. Besova, G.S. Yunaev, I.A. Kurmukov, E.S. Obarevich, D.A. Gavrilova, A.V. Egorova, N.V. Lepkova, A.A. Tryakin
Cardiac toxicity of fluoropyrimidines in the treatment of solid gastrointestinal tumors81-89
L.Yu. Trofimchuk, N.G. Afanasieva
Sentinel lymph node scintigraphy in skin melanoma: personal experience90-93
R.S. Pesotsky, V.F. Semiglazov, P.V. Krivorotko, T.T. Tabagua, K.Yu. Zernov, A.S. Emelyanov, S.S. Ereshchenko, N. Amirov, V.V. Mortada, D.G. Ulrikh, V.E. Levchenko, K.Yu. Rychagov, K.Yu. Zirov, V.N. Evseev
Analysis of the effectiveness of various neoadjuvant chemotherapy regimens in patients with T1-3N1-3M0 I–IIIC stage locally advanced breast cancer94-100
G.M. Teletaeva, E.A. Degtiareva, S.A. Protsenko, D.Kh. Latipova, A.I. Semenova, A.V. Novik, T.Yu. Semiglazova
Anemia in adult cancer patients101-109
M.V. Pchelintsev
Tapentadol is a new drug in an old group. An overview of the use of tapentadol in the treatment of pain in cancer patients110-116
N.I. Mikhailov, A.M. Zaitsev, O.N. Kirsanova, S.A. Kisariev
Spontaneous regression of hormonally inactive pituitary adenoma: a clinical case and literature review117-120
N.V. Dmitrieva, E.R. Mavlyavieva, Yu.V. Chernikova, E.V. Fedotov, T.Sh. Mirilashvili
Combination of sarcoidosis and sigmoid colon cancer: a clinical observation121-124
